Archives for August 18, 2008

← 2008

Further restructuring at Cardinal?

By Gareth Macdonald

Cardinal Health’s announcement that it is considering spinning off some of its divisions has provoked fevered speculation among industry analysts and media observers alike.

Counterfeits take chunk out of TCM sales

By Nick Taylor

The impact counterfeit pharmaceuticals can have on a company’s sales has been highlighted by Tongjitang Chinese Medicines’ (TCM) second quarter results.

G&W receives FDA warning letter

By Nick Taylor

The US Food and Drug Administration (FDA) has issued a warning letter to contract manufacturer G&W Laboratories.

USP opens its first site in Brazil

By Nick Taylor

The US Pharmacopeia (USP) has continued to expand its global reach by opening a site in São Paulo, Brazil; its first in Latin America.

Mallinckrodt and Rubicon to develop PanExcea

By Gareth Macdonald

CRO Rubicon Research and chemicals manufacturer Mallinckrodt Baker are teaming up to develop the PanExcea excipient range, which was launched by the latter firm’s parent company Covidien in July.

Conformia’s platform combined with IBM system

By Gareth Macdonald

Conformia says that the integration of its SOA data platform into IBM’s system will provide drugmakers with robust management architecture for the entire lifecycle of a product.